BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20

• 

  Duchenne muscular dystrophy

  Sarepta Saga Has ‘Gone on Too Long’ as Competitors Catch Up

  After a series of deaths in patients taking Sarepta Therapeutics’ gene therapies, doubt has crept into investor sentiments around the long-time Wall Street darling, and patients may soon begin looking elsewhere.

  February 5, 2026

   · 

  5 min read

   · 

  Dan Samorodnitsky
• Press Releases

  Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies

  February 5, 2026

   · 

  7 min read
• Press Releases

  Beyond Cancer Abstract Featuring Phase 1 Data on Intratumoral Ultra-High Concentration Nitric Oxide (UNO) in Solid Tumor Metastases to be Presented at the AACR Annual Meeting 2026

  February 5, 2026

   · 

  6 min read
• Press Releases

  Teva Canada Announces Approval of Expanded Indication of [Pr]AJOVY® (fremanezumab solution for subcutaneous injection), the First Anti-CGRP Preventive Treatment for Pediatric Episodic Migraine

  February 5, 2026

   · 

  4 min read
• Press Releases

  Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2026

  February 5, 2026

   · 

  3 min read
• Press Releases

  Acarix Receives EU MDR Certification for the CADScor®System

  February 5, 2026

   · 

  2 min read
• Press Releases

  AbbVie Reports Full-Year and Fourth-Quarter 2025 Financial Results

  February 5, 2026

   · 

  25 min read
• Press Releases

  Oncolytics Biotech® Receives FDA Fast Track Designation for Pelareorep in 2L KRAS-Mutant MSS Metastatic Colorectal Cancer

  February 5, 2026

   · 

  6 min read
• Press Releases

  Biodexa Announces Exclusive License of Otsuka’s OPB-171775, a potent Phase 1 ready Molecular Glue for GIST

  February 5, 2026

   · 

  7 min read
• Press Releases

  GRI Bio Reiterates Full Year 2025 Financial Results, Strengthens Balance Sheet and Summarizes Key Recent Highlights

  February 5, 2026

   · 

  7 min read